XJPX
4558
Market cap13mUSD
Oct 09, Last price
200.00JPY
1D
0.00%
1Q
0.00%
Jan 2017
-29.82%
Name
Chukyoiyakuhin Co Ltd
Chart & performance
P/E
25.54
P/S
0.33
EPS
7.83
Div yield, %
2.50%
Shrs. gr., 5y
3.40%
Rev. gr., 5y
2.43%
Revenues
6.57b
+4.16%
Net income
84m
+85.20%
CFO
99m
+212.29%
Dividend
Mar 30, 20272.5 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Chukyoiyakuhin Co.,Ltd. operates across a wide array of sectors, including pharmaceuticals, health and wellness products, beverages, medical devices, beauty items, household goods, apparel, and food. The company also provides life and non-life insurance services. Additionally, it is involved in the manufacturing and distribution of quasi-pharmaceuticals, the production and sale of water, and the fabrication and supply of alcohol-based sterilization products. Established in 1949, the company's main office is located in Handa, Japan.
Key people
Masayuki Yamada
Chairman of the Board, Representative Director · since 2019
Shuji Yonezu
President, Chief Senior Director of Business, Representative Director · since 2019
Takuya Nagata
Executive Officer, Director of Health Care Business Unit · since 2023
Takahira Tomita
Executive Officer, Director in Finance Unit · since 2023
Hiroki Yamamoto
Executive Officer, Director of Marketing Planning · since 2019
Toru Iida
Chief Director of Corporate, Director of System, Director · since 2013
Ikazuchikai Iwasaki
Director of Aquamagic Business, Director · since 2019
Yoshihiro Matsumoto
Chief Senior Director of Business, Director · since 2015
Makoto Tsujimura
Senior Managing Director · since 2009
Nahomi Imaeda
Independent Director · since 2021
Akira Watanabe
Independent Director · since 2016
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||